Caffeine Metabolite May Slow Progression of Nearsightedness in Children
According to a new study, a caffeine metabolite may slow the progression of short-sightedness (myopia) in children.If proved effective in clinical trials, 7-MX could be a valuable future treatment.A metabolite of caffeine, known as 7-MX, may slow the progression of nearsightedness, also known as myopia, in children. This is according to observational research published on August 22, 2022, in the British Journal of Ophthalmology.According to the researchers, 7-MX could become a valuable treatment for a condition for which…